News
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...
About half of adults approve of how Trump is handling transgender issues — a relative high point for a president who has the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results